Notch Therapeutics
Connie L., CPA, CA has over 18 years of work experience, starting in 2003 with Deloitte, where they served as an Audit Senior Manager until 2014. Connie then moved on to Aquinox Pharmaceuticals, Inc. as a Senior Manager in Risk & Compliance, a position they held until 2018. In 2018, Connie joined Xenon Pharmaceuticals Inc. as the Associate Director of Finance, staying with the company until 2019. From 2019 to 2021, they worked as a Finance Accounting Consultant. Currently, Connie serves as the Director and Corporate Controller at Notch Therapeutics, starting in 2021.
Connie L., CPA, CA obtained a Bachelor of Commerce degree in Accounting from The University of British Columbia in 2003.
Notch Therapeutics
Notch is an immune cell therapy company developing a next-generation pipeline of off-the-shelf, universally compatible, genetically tailored T cell therapeutics derived from renewable stem cell sources for the treatment of high-impact diseases, with an initial focus on cancer.